PCM
MRVI icon

Philosophy Capital Management’s Maravai LifeSciences MRVI Stock Holding History

Philosophy Capital Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9M Sell
1,900,000
-737,117
-28% -$3.18M 0.56% 37
2026
Q1 		$7.46M Sell
2,637,117
-463,205
-15% -$1.57M 0.46% 37
2025
Q4 		$10.1M Buy
3,100,322
+507,054
+20% +$1.71M 0.46% 38
2025
Q3 		$7.44M Hold
2,593,268
– – 0.3% 39
2025
Q2 		$6.25M Hold
2,593,268
– – 0.31% 34
2025
Q1 		$5.73M Buy
+2,593,268
New +$10.2M 0.41% 36

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Philosophy Capital Management's MRVI Position: Q2 2026 in Review

Philosophy Capital Management reduced its Maravai LifeSciences (MRVI) stake by 28% in Q2 2026, selling an estimated $3.18M and leaving 1,900,000 shares worth $11.9M. The position accounts for 0.56% of the portfolio, ranked #37.

Philosophy Capital Management first reported a position in MRVI in Q1 2025 and has held it in 6 quarters since. 177 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Philosophy Capital Management held 1,900,000 shares of Maravai LifeSciences worth $11.9M as of Q2 2026.
  • Philosophy Capital Management sold 737,117 Maravai LifeSciences shares in Q2 2026, an estimated $3.18M.
  • Maravai LifeSciences made up 0.56% of Philosophy Capital Management's portfolio in Q2 2026, its #37 holding.
  • Philosophy Capital Management first reported a position in Maravai LifeSciences in Q1 2025 and has held it in 6 quarters since.
  • 177 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Philosophy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.